Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| NewAge, Inc.NBEV · Entity 129046 | Chief Operating Officer | January 24, 2020 | January 28, 2020 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
NewAge, Inc.
Report date January 24, 2020 · Filed January 28, 2020
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 125,000 |
Reported balance
After 2020-01-24 transaction · row 1
1 source rowRow 1 · 2020-01-24 · Grant · Acquired 125,000 · Balance 125,000 F1: The restricted stock vests as follows: 33% on January 13, 2021, 33% on January 13, 2022 and 34% on January 13, 2023. |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $1.77 · Expires 2030-01-13 | Direct | 125,000 |
Reported balance
After 2020-01-24 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2020-01-24 · Grant · Acquired 125,000 · Balance 125,000 F2: The option vests as follows: 33% on January 13, 2021, 33% on January 13, 2022 and 34% on January 13, 2023. |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $1.77 · Expires 2029-08-15 | Direct | 5,000 |
Reported balance
After 2020-01-24 transaction · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · 2020-01-24 · Grant · Acquired 5,000 · Balance 5,000 F3: The option vests as follows: 33% on August 15, 2020, 33% on August 15, 2021 and 34% on August 15, 2022. |
| Common StockSEC Table I · non-derivative | IndirectBy spouse | 3,000 |
Reported balance
Holding disclosure · report date 2020-01-24 · row 2
Holding and transaction disclosures are not merged.
1 source rowRow 2 · Balance 3,000 |
Filing footnotes · ownership attribution and instrument terms
F1: The restricted stock vests as follows: 33% on January 13, 2021, 33% on January 13, 2022 and 34% on January 13, 2023.
F2: The option vests as follows: 33% on January 13, 2021, 33% on January 13, 2022 and 34% on January 13, 2023.
F3: The option vests as follows: 33% on August 15, 2020, 33% on August 15, 2021 and 34% on August 15, 2022.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
Prenetics Global Ltd
Report date June 15, 2026 · Filed June 16, 2026
Section 16 reporting ended · disclosed 2026-06-16. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Class A Ordinary Share, par value $0.0015 per shareSEC Table I · non-derivative | Direct | 45,249 |
Reported balance
After 2026-06-15 transaction · row 1
1 source rowRow 1 · 2026-06-15 · Exercise / conversion · Acquired 6,944 · Balance 45,249 F1: Represents 6,944 Class A Ordinary Shares of the Issuer issued and delivered upon settlement of vested Restricted Stock Units ("RSUs") granted under the Issuer's 2022 Share Incentive Plan. Any unvested RSUs were forfeited in connection with David Vanderveen's termination of services as director of the Issuer. |
| Restricted Stock UnitSEC Table II · derivative / convertible security · Conversion / exercise price $0.00 · Expires 2032-07-15 | Direct | 0 |
Reported balance
After 2026-06-15 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2026-06-15 · Exercise / conversion · Disposed 8,681 · Balance 0 F2: Each RSU, granted under the Issuer's 2022 Share Incentive Plan, represents a contingent right to receive one Class A Ordinary Share. 6,944 RSUs vested and were settled and delivered in shares on June 15, 2026. Any remaining unvested RSUs were forfeited in connection with termination of service. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents 6,944 Class A Ordinary Shares of the Issuer issued and delivered upon settlement of vested Restricted Stock Units ("RSUs") granted under the Issuer's 2022 Share Incentive Plan. Any unvested RSUs were forfeited in connection with David Vanderveen's termination of services as director of the Issuer.
F2: Each RSU, granted under the Issuer's 2022 Share Incentive Plan, represents a contingent right to receive one Class A Ordinary Share. 6,944 RSUs vested and were settled and delivered in shares on June 15, 2026. Any remaining unvested RSUs were forfeited in connection with termination of service.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 15, 2026 Filed Jun 16, 2026 12:38 UTC | Prenetics Global Ltd PRE · Entity 2718 | Exercise / conversionRestricted Stock Unit · Derivative | 8,681 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001628280-26-043430 · wk-form4_1781613530.xml · derivative · entry 2 VANDERVEEN DAVID · CIK 0001167191 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Class A Ordinary Share, par value $0.0015 per share · 8,681 shares Expires 2032-07-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Each RSU, granted under the Issuer's 2022 Share Incentive Plan, represents a contingent right to receive one Class A Ordinary Share. 6,944 RSUs vested and were settled and delivered in shares on June 15, 2026. Any remaining unvested RSUs were forfeited in connection with termination of service. Read SEC document |
| June 15, 2026 Filed Jun 16, 2026 12:38 UTC | Prenetics Global Ltd PRE · Entity 2718 | Exercise / conversionClass A Ordinary Share, par value $0.0015 per share | 6,944 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-26-043430 · wk-form4_1781613530.xml · nonDerivative · entry 1 VANDERVEEN DAVID · CIK 0001167191 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 45,249 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Represents 6,944 Class A Ordinary Shares of the Issuer issued and delivered upon settlement of vested Restricted Stock Units ("RSUs") granted under the Issuer's 2022 Share Incentive Plan. Any unvested RSUs were forfeited in connection with David Vanderveen's termination of services as director of the Issuer. Read SEC document |
| January 24, 2020 Filed Jan 28, 2020 21:30 UTC | NewAge, Inc. NBEV · Entity 129046 | GrantStock Option (Right to Buy) · Derivative | 5,000 | $0.00 Strike: $1.77 | $0.00 |
DisclosureSEC source: 0001493152-20-001248 · ownership.xml · derivative · entry 4 VANDERVEEN DAVID · CIK 0001167191 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,000 Underlying: Common Stock · 5,000 shares Expires 2029-08-15 F3 · derivative.exercise_date: The option vests as follows: 33% on August 15, 2020, 33% on August 15, 2021 and 34% on August 15, 2022. Read SEC document |
| January 24, 2020 Filed Jan 28, 2020 21:30 UTC | NewAge, Inc. NBEV · Entity 129046 | GrantStock Option (Right to Buy) · Derivative | 125,000 | $0.00 Strike: $1.77 | $0.00 |
DisclosureSEC source: 0001493152-20-001248 · ownership.xml · derivative · entry 3 VANDERVEEN DAVID · CIK 0001167191 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 125,000 Underlying: Common Stock · 125,000 shares Expires 2030-01-13 F2 · derivative.exercise_date: The option vests as follows: 33% on January 13, 2021, 33% on January 13, 2022 and 34% on January 13, 2023. Read SEC document |
| January 24, 2020 Filed Jan 28, 2020 21:30 UTC | NewAge, Inc. NBEV · Entity 129046 | GrantCommon Stock | 125,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001493152-20-001248 · ownership.xml · nonDerivative · entry 1 VANDERVEEN DAVID · CIK 0001167191 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 125,000 F1 · shares: The restricted stock vests as follows: 33% on January 13, 2021, 33% on January 13, 2022 and 34% on January 13, 2023. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.